PILL ETF holdings (NYSE) | MetaTrader

Tam grafiği aç Full chart

Genel Bakış Tüm yatırımlar Isı Haritası

En büyük yatırımlar Market Value Shares Weight %

GOLDMAN FINANCIAL 4.2 M 4.2 M 23.6%

GOLDMAN SACHS LIQ ES FD A 870.0 K 870.0 K 4.9%

DREYFUS GOVERNMENT CASH MANAGE 799.1 K 799.1 K 4.5%

DFTX Definium Therapeutics Inc. 349.4 K 20.7 K 1.9%

LQDA Liquidia Corporation 332.4 K 7 842.0 1.9%

MBX MBX Biosciences, Inc. 327.7 K 8 892.0 1.8%

AXSM Axsome Therapeutics Inc. 316.4 K 1 717.0 1.8%

OGN Organon & Co 304.8 K 35.7 K 1.7%

EWTX Edgewise Therapeutics Inc. 303.9 K 10.8 K 1.7%

ELAN Elanco Animal Health Inc 289.7 K 12.0 K 1.6%

MRK Merck & Co., Inc 289.3 K 2 624.0 1.6%

VTRS Viatris Inc 289.1 K 22.1 K 1.6%

AMRX Amneal Pharmaceuticals Inc 287.1 K 21.0 K 1.6%

JNJ Johnson & Johnson 281.8 K 1 240.0 1.6%

RPRX Royalty Pharma PLC 279.3 K 6 700.0 1.6%

AMLX Amylyx Pharmaceuticals Inc 276.8 K 19.4 K 1.5%

BMY Bristol-Myers Squibb Company 275.5 K 5 005.0 1.5%

XERS Xeris Biopharma Holdings Inc 271.7 K 36.9 K 1.5%

ZTS Zoetis Inc. 271.0 K 2 171.0 1.5%

PRGO Perrigo Company PLC 269.3 K 19.0 K 1.5%

1
2
3
4

Haberler

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

Defensive Stocks: A Potential Antidote To Inflation Shocks

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies